The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer

William A. Freed-Pastor(Harvard University), Laurens J. Lambert(Massachusetts Institute of Technology), Zackery A. Ely(Massachusetts Institute of Technology), Nimisha B. Pattada(Massachusetts Institute of Technology), Arjun Bhutkar(Massachusetts Institute of Technology), George Eng(Massachusetts General Hospital), Kim L. Mercer(Massachusetts Institute of Technology), Ana Patiño‐García(Massachusetts Institute of Technology), Lin Lin(Massachusetts Institute of Technology), William M. Rideout(Massachusetts Institute of Technology), William L. Hwang(Broad Institute), Jason M. Schenkel(Brigham and Women's Hospital), Alex M. Jaeger(Massachusetts Institute of Technology), Roderick T. Bronson(Massachusetts Institute of Technology), Peter M.K. Westcott(Massachusetts Institute of Technology), Tyler Hether(Nanostring Technologies (United States)), Prajan Divakar(Nanostring Technologies (United States)), Jason Reeves(Nanostring Technologies (United States)), Vikram Deshpande(Massachusetts General Hospital), Toni Delorey(Broad Institute), Devan Phillips(Broad Institute), Omer H. Yilmaz(Massachusetts General Hospital), Aviv Regev(Broad Institute), Tyler Jacks(Massachusetts Institute of Technology)
Cancer Cell
August 5, 2021
Cited by 261Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis